You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Merck
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Heritage Pharms Inc Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HERITAGE PHARMS INC, and what generic and branded alternatives to HERITAGE PHARMS INC drugs are available?

HERITAGE PHARMS INC has forty approved drugs.



Summary for Heritage Pharms Inc
US Patents:0
Tradenames:37
Ingredients:36
NDAs:40

Drugs and US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074877-001 Jul 8, 1997 DISCN No No   Start Trial   Start Trial
Heritage Pharms Inc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 207433-004 May 5, 2016 AB RX No No   Start Trial   Start Trial
Heritage Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 201336-002 Oct 1, 2012 DISCN No No   Start Trial   Start Trial
Heritage Pharms Inc DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 200856-002 Apr 30, 2013 AB RX No No   Start Trial   Start Trial
Heritage Pharms Inc ACYCLOVIR acyclovir TABLET;ORAL 074891-002 Oct 31, 1997 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Heritage Pharms Inc LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 4,316,897   Start Trial
Heritage Pharms Inc LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 4,316,897   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
McKinsey
Mallinckrodt
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.